These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug-eluting balloon: very short-term exposure and overlapping. Cremers B; Speck U; Kaufels N; Mahnkopf D; Kühler M; Böhm M; Scheller B Thromb Haemost; 2009 Jan; 101(1):201-6. PubMed ID: 19132209 [TBL] [Abstract][Full Text] [Related]
6. Novel Sirolimus-Coated Balloon Catheter: In Vivo Evaluation in a Porcine Coronary Model. Clever YP; Peters D; Calisse J; Bettink S; Berg MC; Sperling C; Stoever M; Cremers B; Kelsch B; Böhm M; Speck U; Scheller B Circ Cardiovasc Interv; 2016 Apr; 9(4):e003543. PubMed ID: 27069105 [TBL] [Abstract][Full Text] [Related]
7. Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Speck U; Cremers B; Kelsch B; Biedermann M; Clever YP; Schaffner S; Mahnkopf D; Hanisch U; Böhm M; Scheller B Circ Cardiovasc Interv; 2012 Jun; 5(3):392-400. PubMed ID: 22619258 [TBL] [Abstract][Full Text] [Related]
8. A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions. Gemeinhardt O; Schnorr B; Speck U; Scheller B PLoS One; 2021; 16(10):e0259106. PubMed ID: 34714843 [TBL] [Abstract][Full Text] [Related]
9. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries. Cremers B; Kelsch B; Clever YP; Hattangadi N; Mahnkopf D; Speck U; Taupitz M; Scheller B Clin Res Cardiol; 2012 May; 101(5):385-91. PubMed ID: 22237489 [TBL] [Abstract][Full Text] [Related]
12. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels. Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Drug-Coated Balloon and Drug-Eluting Stent for the Treatment of Small Vessel Disease (from the Dissolve SVD Randomized Trial). Liu S; Zhou Y; Shen Z; Chen H; Qiu C; Fu G; Li H; Yu Z; Zeng Q; Li Z; Li W; Qiao S; Am J Cardiol; 2024 Jan; 211():29-39. PubMed ID: 37995506 [TBL] [Abstract][Full Text] [Related]
14. Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results. Brodmann M; Werner M; Meyer DR; Reimer P; Krüger K; Granada JF; Jaff MR; Schroeder H; JACC Cardiovasc Interv; 2018 Dec; 11(23):2357-2364. PubMed ID: 30522663 [TBL] [Abstract][Full Text] [Related]